Desktop Site
|
26 Jul 24 | 15:59
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
81,332.72
+1,292.92
+1.62 %
Corporate Announcement
Security Code
530549
Company
Shilpa Medicare Ltd
Exchange Received Time
23/07/2024 12:05:32
Exchange Disseminated Time
23/07/2024 12:05:32
Time Taken
00:00:00
Important Milestone For The Biologics Business Of Shilpa Medicare Limited ('SML')Shilpa Biologics Pvt Ltd ('SBPL') Receives First International Market Approval For Adalimumab 40 Mg/0.4 Ml Solution For Injection In MOROCCO |
7/23/2024 12:05:32 PM
Shilpa Biologicals private limited a wholly owned subsidiary of the Company has registration approval for Adalimumab from morocco, MOH. This is the first biosimilar approval from any international market for high concentration adalimumab developed by SBPL.
Attachment
<< Back
Recently Viewed